PlainPharmaWatch

CMS Open Payments · Tool

CSL Behring vs Zimmer Biomet Holdings, Inc.

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Zimmer Biomet Holdings, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 1,031, versus 91 for the other company. Its single largest recorded recipient represents 0.3% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

CSL Behring
HHI 91 · top recipient 0.0%
Ranked #1,702 of 1,838 companies by HHI
Zimmer Biomet Holdings, Inc.
HHI 1,031 · top recipient 0.3%
Ranked #1,018 of 1,838 companies by HHI

Payment Overview

Company A

CSL Behring

Total Payments
$88.2M
% of Industry
0.6%
Transactions
33,578
Avg per Transaction
$2.6K
Recipients
27,644
Avg per Recipient
$3.2K
Payment Types
10
Top Payment Type
Compensation for Services Other Than Consulting
Total Payments
$88.6M
% of Industry
0.6%
Transactions
34,372
Avg per Transaction
$2.6K
Recipients
33,496
Avg per Recipient
$2.6K
Payment Types
11
Top Payment Type
Acquisitions

Highlighted values indicate the higher figure for each metric.

Total payments compared

CSL Behring vs Zimmer Biomet Holdings, Inc. - total reported payments in CMS Open Payments PY2024

Zimmer Biomet Holdings, Inc.$88.6MCSL Behring$88.2M

Payment Types Breakdown

CSL Behring

Compensation for Services Other Than Consulting $1.9M

2.1%

Consulting Fee $986.8K

1.1%

Food and Beverage $667.6K

0.8%

Travel and Lodging $626.5K

0.7%

Grant $353.5K

0.4%

Royalty or License $162.9K

0.2%

Zimmer Biomet Holdings, Inc.

Acquisitions $40.1M

45.3%

Royalty or License $27.9M

31.5%

Education $6.4M

7.2%

Consulting Fee $4.8M

5.4%

Travel and Lodging $2.2M

2.5%

Food and Beverage $1.4M

1.6%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

CSL Behring

  1. 1

    RICHARD S. LEMONS

    $194,480.68 · 245 txns

  2. 2

    Hospital Of The Univ Of Penna

    $170,500.00 · 3 txns

  3. 3

    Seattle Childrens Hospital

    $108,801.45 · 13 txns

  4. 4

    RAFFI TACHDJIAN

    $108,035.14 · 105 txns

  5. 5

    JOHN LUBER

    $98,999.85 · 68 txns

Zimmer Biomet Holdings, Inc.

  1. 1

    NITIN GOYAL

    $25,000,264.39 · 6 txns

  2. 2

    ERIK KUBIAK

    $7,390,410.50 · 7 txns

  3. 3

    COLIN POOLE

    $3,199,557.39 · 2 txns

  4. 4

    AARON HOFMANN

    $2,593,980.00 · 1 txns

  5. 5

    JONATHAN YERASIMIDES

    $1,925,363.72 · 181 txns

Summary Comparison

Metric CSL Behring Zimmer Biomet Holdings, Inc.
Total Payments $88.2M $88.6M
% of Industry Total 0.6% 0.6%
Transaction Count 33,578 34,372
Avg per Transaction $2.6K $2.6K
Recipient Count 27,644 33,496
Avg per Recipient $3.2K $2.6K
Payment Type Count 10 11
Top Payment Type Compensation for Services Other Than Consulting Acquisitions

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.